Episode Details

Back to Episodes

Amcor (AMCR) Q4 FY2026: The Growth Was Bought, Not Earned

Published 3 days, 19 hours ago
Description
Amcor plc (AMCR) Q4 FY2026 — Q4 FY2026 (quarter ended June 30, 2026): net sales $6,398M, up 26% and $344M ahead. Adjusted EPS $1.23 vs a $1.19 bar, up 23%. GAAP EPS $0.83. Adjusted EBIT $836M. FY26 free cash flow $1,303M. Stock -1.77% to $46.56. Amcor beat on both lines and grew adjusted EPS 23%, and the stock opened higher then sold off all session. Its own growth bridge says why: of the 26% rise in sales, 19 points were the Berry acquisition, 6 were raw-material pass-through and 2 were currency, leaving organic sales at MINUS 1% with volume flat. THE CALL: HOLD (3/5, A REAL BEAT WITH NO GROWTH UNDERNEATH IT) — base-case value ~$45.0 vs ~$46.38 today. KEY METRICS: - CALL: HOLD, 3/5. Fair value ~$45.00 vs the $46.38 close, 3% below - we are close to Wall Street on PRICE and far apart on the REASON. Consensus is a Buy at a $48.18 target, under 4% of upside. What holds this share price up is a 5.6% dividend covered just 1.08x by reported cash flow, not growth. We model $4.10 of forward EPS against the Street's $4.59, about 11% lower. - THE GROWTH BRIDGE, FROM AMCOR'S OWN TABLE: net sales +26% is +19 points of acquisitions net of divestitures (~$962M of Berry), +6 points of raw-material pass-through (~$280M, which carries essentially no margin), +2 points of currency, and ORGANIC -1%. Volume was flat, price/mix -1%. For the full year: organic -2%, volume -2%. Two straight years without underlying growth. - SYNERGIES AND CURRENCY WERE WORTH MORE THAN THE GROWTH: Berry synergy in adjusted EBIT ran $33M, $50M, $57M and $100M by quarter - exactly the $240M the full year reports. Taxed at the 16.8% rate Amcor paid, over 463.8M diluted shares, that is $0.43 a share. Currency added ~$0.11 (13% reported EPS growth, 10% constant currency). Actual growth was $0.46, $3.56 to $4.02. - THE GUIDE NOBODY READ: Amcor is moving its year end from June 30 to December 31, so instead of a full year it guided a six-month Transition Period, July-December 2026, at $1.80-$1.90. The same six months a year earlier earned $1.83. That is -1.6% to +3.8%, about +1% at the midpoint - right after a +23% quarter. Berry closed April 30, 2025, so the comparison is clean. - CASH, DIVIDEND AND DEBT: FY26 free cash flow was $1,303M against guidance of $1.8-1.9B in November, cut to $1.5-1.6B in May. The first nine months generated MINUS $93M - the whole year arrived in the June quarter on an $849M working-capital release. Dividends paid were $1,195M, 92% of it. Net debt is $12,897M and leverage is guided HIGHER, to 3.5x-3.6x, by December. What to watch: UP: two consecutive quarters of positive organic volume, which would give the remaining ~$410M of Berry synergies something to compound against. DOWN: a December leverage print above the guided 3.5x-3.6x while the dividend still runs at 92% of free cash flow. Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us